139 related articles for article (PubMed ID: 6345245)
1. Retrograde axonal transport of intravenously administered 125I-nerve growth factor in rats with streptozotocin-induced diabetes.
Schmidt RE; Modert CW; Yip HK; Johnson EM
Diabetes; 1983 Jul; 32(7):654-63. PubMed ID: 6345245
[TBL] [Abstract][Full Text] [Related]
2. Retrograde axonal transport of 125I-nerve growth factor in rat ileal mesenteric nerves. Effect of streptozocin diabetes.
Schmidt RE; Plurad SB; Saffitz JE; Grabau GG; Yip HK
Diabetes; 1985 Dec; 34(12):1230-40. PubMed ID: 2415414
[TBL] [Abstract][Full Text] [Related]
3. Retrograde axonal transport in rat ileal mesenteric nerves. Characterization using intravenously administered 125I-nerve growth factor and effect of chemical sympathectomy.
Schmidt RE; Yip HK
Diabetes; 1985 Dec; 34(12):1222-9. PubMed ID: 2415413
[TBL] [Abstract][Full Text] [Related]
4. Retrograde axonal transport of [125I]nerve growth factor in ileal mesenteric nerves in vitro: effect of streptozotocin diabetes.
Schmidt RE; Grabau GG; Yip HK
Brain Res; 1986 Jul; 378(2):325-36. PubMed ID: 2425904
[TBL] [Abstract][Full Text] [Related]
5. Selective susceptibility of different populations of sympathetic neurons to diabetic neuropathy in vivo is reflected by increased vulnerability to oxidative stress in vitro.
Semra YK; Wang M; Peat NJ; Smith NC; Shotton HR; Lincoln J
Neurosci Lett; 2006 Oct; 407(3):199-204. PubMed ID: 16973273
[TBL] [Abstract][Full Text] [Related]
6. Experimental diabetic autonomic neuropathy characterization in streptozotocin-diabetic Sprague-Dawley rats.
Schmidt RE; Plurad SB; Modert CW
Lab Invest; 1983 Nov; 49(5):538-52. PubMed ID: 6632773
[TBL] [Abstract][Full Text] [Related]
7. Effect of streptozotocin-induced diabetes on NGF, P75(NTR) and TrkA content of prevertebral and paravertebral rat sympathetic ganglia.
Schmidt RE; Dorsey DA; Roth KA; Parvin CA; Hounsom L; Tomlinson DR
Brain Res; 2000 Jun; 867(1-2):149-56. PubMed ID: 10837808
[TBL] [Abstract][Full Text] [Related]
8. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy.
Hellweg R; Hartung HD
J Neurosci Res; 1990 Jun; 26(2):258-67. PubMed ID: 2142224
[TBL] [Abstract][Full Text] [Related]
9. Effect of NGF and neurotrophin-3 treatment on experimental diabetic autonomic neuropathy.
Schmidt RE; Dorsey DA; Beaudet LN; Parvin CA; Escandon E
J Neuropathol Exp Neurol; 2001 Mar; 60(3):263-73. PubMed ID: 11245210
[TBL] [Abstract][Full Text] [Related]
10. Reduction by reserpine of the accumulation of retrogradely transported [125I]nerve growth factor in sympathetic neurons.
Johnson EM; Blumberg HM; Costrini NV; Bradshaw RA
Brain Res; 1979 Dec; 178(2-3):389-401. PubMed ID: 92350
[TBL] [Abstract][Full Text] [Related]
11. The significance of retrograde axonal transport for the accumulation of systemically administered nerve growth factor (NGF) in the rat superior cervical ganglion.
Stoeckel K; Guroff G; Schwab M; Thoenen H
Brain Res; 1976 Jun; 109(2):271-84. PubMed ID: 58700
[TBL] [Abstract][Full Text] [Related]
12. Biological importance of retrograde axonal transport of nerve growth factor in adrenergic neurons.
Paravicini U; Stoeckel K; Thoenen H
Brain Res; 1975 Feb; 84(2):279-91. PubMed ID: 46156
[TBL] [Abstract][Full Text] [Related]
13. NGF protects paravertebral but not prevertebral sympathetic neurons against exposure to high glucose in vitro.
Semra YK; Sherif S; Lincoln J
Brain Res; 2009 Aug; 1285():164-73. PubMed ID: 19505442
[TBL] [Abstract][Full Text] [Related]
14. Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy.
Schmidt RE; Dorsey DA; Beaudet LN; Parvin CA; Zhang W; Sima AA
J Neuropathol Exp Neurol; 2004 May; 63(5):450-60. PubMed ID: 15198124
[TBL] [Abstract][Full Text] [Related]
15. The effects of drug which destroy the sympathetic nervous system on the retrograde transport of nerve growth factor.
Johnson EM; Macia RA; Andres RY; Bradshaw RA
Brain Res; 1979 Aug; 171(3):461-72. PubMed ID: 89888
[TBL] [Abstract][Full Text] [Related]
16. The effect of pancreatic islet transplantation and insulin therapy on experimental diabetic autonomic neuropathy.
Schmidt RE; Plurad SB; Olack BJ; Scharp DW
Diabetes; 1983 Jun; 32(6):532-40. PubMed ID: 6414860
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the retrograde transport of nerve growth factor (NGF) using high specific activity [125I] NGF.
Johnson EM; Andres RY; Bradshaw RA
Brain Res; 1978 Jul; 150(2):319-31. PubMed ID: 209849
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of sorbitol dehydrogenase exacerbates autonomic neuropathy in rats with streptozotocin-induced diabetes.
Schmidt RE; Dorsey DA; Beaudet LN; Plurad SB; Parvin CA; Yarasheski KE; Smith SR; Lang HJ; Williamson JR; Ido Y
J Neuropathol Exp Neurol; 2001 Dec; 60(12):1153-69. PubMed ID: 11764088
[TBL] [Abstract][Full Text] [Related]
19. Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy.
Hellweg R; Raivich G; Hartung HD; Hock C; Kreutzberg GW
Exp Neurol; 1994 Nov; 130(1):24-30. PubMed ID: 7821393
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the binding properties and retrograde axonal transport of a monoclonal antibody directed against the rat nerve growth factor receptor.
Taniuchi M; Johnson EM
J Cell Biol; 1985 Sep; 101(3):1100-6. PubMed ID: 2411735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
